Questcor Pharmaceuticals, Inc. (QCOR) Buys Potential Rival Drug
Why try to beat 'em if you can just buy 'em? That's the approach that Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) is taking.
Posts Tagged ‘NYSE:NVS’
Celgene Corporation (CELG)’s Abraxane: A Therapy for Advanced Pancreatic Cancer?
Celgene Corporation (NASDAQ:CELG)’s Abraxane is primarily used to treat breast and lung cancer.
Merck & Co., Inc. (MRK), Clovis Oncology Inc (CLVS): All About ASCO – 2013 Highlights
Every week at The Motley Fool we reflect on the top stories in the biotech sector in a wrap-up column.
Johnson & Johnson (JNJ), VIVUS, Inc. (VVUS): The Three Biggest Risk Factors for a Stroke
Often referred to as "the silent killer," stroke is the fourth-leading cause of the death in the U.S., behind only heart disease, cancer, and chronic lower respiratory diseases...
Threshold Pharmaceuticals, Inc. (THLD), Celgene Corporation (CELG)- Tackling Cancer: Pancreatic Cancer’s Biggest Current & Upcoming Players
As I noted 12 weeks ago, cancer statistics are both staggering and disappointing.
Gilead Sciences, Inc. (GILD)’s Entry Into Cancer Therapy
It is interesting to watch a bio company change tactics and go into an area it hasn't explored before. This, to me, is like watching a child suddenly grow up.
Novartis AG (ADR) (NVS), Sanofi SA (ADR) (SNY): Pharma Big Wigs Warm Up to Africa’s $40 Billion Opportunity
For a long time, Africa’s traditional enemy with regard to diseases have been communicable diseases like HIV and Malaria. Now, however, this trend is changing.
Hedge Funds Are Selling GlaxoSmithKline plc (ADR) (GSK)
If you'd ask most stock holders, hedge funds are assumed to be underperforming, outdated financial vehicles of yesteryear.
Novartis AG (ADR) (NVS): Are Hedge Funds Right About This Stock?
Novartis AG (ADR) (NYSE:NVS) was in 24 hedge funds' portfolio at the end of March.
Does Novartis AG (ADR) (NVS) Pass Buffett’s Test?
We'd all like to invest like the legendary Warren Buffett, turning thousands into millions or more.
Valeant Pharmaceuticals Intl Inc (VRX) is Expanding its Eye Care Business
The pharmaceutical industry is getting hotter with increasing M&A activities.
Novartis AG (ADR) (NVS), Alexion Pharmaceuticals, Inc. (ALXN), Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX): 4 Companies Riding the Orphan Drug Rocket
A recent report by EvaluatePharma claims that sales of orphan drugs -- ones that target rare diseases -- will grow at twice the rate of the overall prescription market.
Hedge Funds Are Dumping GlaxoSmithKline plc (ADR) (GSK)
GlaxoSmithKline plc (ADR) (NYSE:GSK) was in 18 hedge funds' portfolio at the end of March. GSK investors should be aware of a decrease in enthusiasm from smart money lately.
This Metric Says You Are Smart to Buy Sanofi SA (ADR) (SNY)
To most investors, hedge funds are seen as slow, outdated financial vehicles of the past.
Johnson & Johnson (JNJ), Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): Is There Growth Left in Massive Drug Stocks?
In an already massive market segment, are dividends all you can hope for when you hunt down "elephants" like Warren Buffett does? While you probably won't get a five-bagger at...
Pfizer Inc. (PFE) Stock Checkup for May
We dread some checkups. Some people even put them off. If you own Pfizer Inc. (NYSE:PFE) stock, though, there's no need for dread or delay.
Santarus, Inc. (SNTS) Is a Real Gas!
Investing in the stock market can sometimes be a gut wrenching experience. However, for investors in Santarus, Inc.
The Home Depot, Inc. (HD), BP plc (ADR) (BP) & The Five Richest Countries in the World
The recession has taken a toll on economies around the world, from driving down standards of living to sending unemployment to record levels.
Ariad Pharmaceuticals, Inc. (ARIA), Pfizer Inc. (PFE), Celgene Corporation (CELG): Who’s The Best?
Investors emphasize the "bio" in biotech a great deal. We look at how much patients' health improved in clinical trials.
Myriad Genetics, Inc. (MYGN), Roche Holding Ltd. (ROG): Angelina Jolie’s Selfless Act Heightens Breast Cancer Awareness
I admit to not being a big fan of many of her movies -- possibly the only man on the planet who will admit so -- but there's little denying that movie sensation Angelina Jolie...
3M Co (MMM), Thermo Fisher Scientific Inc. (TMO): The Hidden Opportunity of the Novel Coronavirus
According to the Center for Disease Control and Prevention, there are only five known coronaviruses that can infect humans.
Allergan, Inc. (AGN): Is It Worth Looking At?
Allergan, Inc. (NYSE:AGN) has been consistently increasing on the market since the market bottom, from nearly $32 per share in November 2008 to more than $116 per share in ...
Pfizer Inc. (PFE): Risks, Hesitations & Key Opportunities
Take a look around the pharmaceutical industry and you won't find many companies with market caps exceeding $100 billion (seven by my count).
Merck & Co., Inc. (MRK), Novartis AG (ADR) (NVS), Pfizer Inc. (PFE): Six Big Pharma Stocks With Lower Credit Risk Than U.S. Treasuries: Part II
The healthcare sector has been known for paying dependable dividends and producing strong total returns over time.
GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX): Take a Deep Breath Before This Big FDA Decision
Every Sunday I make it a point to examine a combination of earnings stories or Food and Drug Administration panel reviews or PDUFA decisions in the upcoming week that you can'...
Allergan, Inc. (AGN), Regeneron Pharmaceuticals Inc (REGN), And What You Should Know
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Pfizer Inc. (PFE), Eli Lilly & Co. (LLY) & Other Names To Know: A Full Breakdown
Investing in biotech companies can be intimidating, especially for investors without a science background. But there's hope.
Who’s Suing Novartis AG (ADR) (NVS), And Why?
Would you hold a pharmaceutical product presentation in Hooters? That's just one of many alleged instances that the U.S.
Pfizer Inc. (PFE), Novartis AG (ADR) (NVS), GlaxoSmithKline plc (ADR) (GSK) & Big Pharma’s Kickback Conundrum
Big pharma is a controversial industry. Along with tobacco companies, they are some of the most vilified businesses in the world.
Intel Corporation (INTC), Vodafone Group Plc (ADR) (VOD), and Novartis AG (ADR) (NVS): Three Misunderstood Large Cap Value Finds
Perkins Large Cap Value Fund (JNPLX) looks for temporarily misunderstood companies.
Biogen Idec Inc. (BIIB) Bounces Higher
If you thought that the great run so far in 2013 was over for Biogen Idec Inc. (NASDAQ:BIIB), think again.
Novartis AG (ADR) (NVS), Sanofi SA (ADR) (SNY), Regeneron Pharmaceuticals Inc (REGN): Three Potential Game Changers for America’s No. 1 Killer
Heart disease kills nearly 600,000 Americans every year, making it the nation's No. 1 cause of death, according to the Centers for Disease Control and Prevention.
Sanofi SA (ADR) (SNY), Johnson & Johnson (JNJ), and Investing in Potential Blockbusters
A popular drug that crosses a benchmark sale of $1 billion for the manufacturer is called a blockbuster drug.
Pfizer Inc. (PFE) & More…a ‘Breakthrough’ May Be on the Way for Breast Cancer Patients
The process of developing a drug from start to finish is incredibly arduous, usually involves around $1 billion in costs, and can take upwards of a decade to complete.
ACADIA Pharmaceuticals Inc. (ACAD), Pfizer Inc. (PFE): This Stock Is Fine, So What Just Happened to Mine?
While the Dow Jones Industrial Average (INDEXDJX:.DJI) continues to climb to new heights on little more than a central bank-induced asset levitation scheme and closing the day...
Do Hedge Funds and Insiders Love Johnson & Johnson (JNJ)?
Johnson & Johnson (NYSE:JNJ) was in 67 hedge funds' portfolio at the end of December. JNJ has experienced a decrease in hedge fund interest in recent months.
Abbott Laboratories (ABT): This Company & Ache Labs: A Perfect Match?
Abbott Laboratories (NYSE:ABT) has begun its new future swimmingly.
Pfizer Inc. (PFE): Could Novartis AG (ADR) (NVS) Decision Bring Pharma Sector Rotation?
Over the last year the biggest drug makers, like Pfizer Inc.
Biogen Idec Inc. (BIIB), Sanofi SA (ADR) (SNY), Elan Corporation, plc (ADR) (ELN): The Greatest Thing Since Sliced Bread Has Arrived for MS Patients
Last November, I examined five experimental drugs that appeared as if they had all of the tools necessary to become life-changing blockbusters from a financial and quality of ...
Do Hedge Funds and Insiders Love Novartis AG (ADR) (NYSE:NVS)?
At the moment, there are tons of gauges market participants can use to track the equity markets. A duo of the best are hedge fund and insider trading sentiment.
Pfizer Inc. (PFE), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Decision Looms on New Multiple Sclerosis Drug
Will good news from Europe echo on this side of the Atlantic within the next few days? Biogen Idec Inc. (NASDAQ:BIIB) is certainly hoping so.
AstraZeneca plc (ADR) (AZN), Sanofi SA (ADR) (SNY), GlaxoSmithKline plc (ADR) (GSK): Is It Worth Getting a Flu Shot? The Answer May Surprise You…
Every year, it appears that flu season starts earlier and earlier, and somehow, every year, the virus mutates into its "most virulent form ever." Sometimes it's a wonder we even...
GlaxoSmithKline plc (ADR) (GSK), Pfizer Inc. (PFE): Is Novartis AG (ADR) (NVS) a Cash King?
In this series, we'll highlight four companies in an industry, and compare their "cash king margins" over time, trying to determine which has the greatest likelihood of putting...
Pfizer Inc. (PFE), Celgene Corporation (CELG): Tackling Cancer: Lung Cancer’s Biggest Current and Upcoming Players
As I noted three weeks ago, cancer statistics are both staggering and disappointing.
Microsoft Corporation (MSFT), Intel Corporation (INTC), GlaxoSmithKline plc (ADR) (GSK): 8 Projects Bringing Synthetic Biology to Your Doorstep
Bacteria have been Public Enemy No. 1 for most of our species' time on Earth.
Insmed Incorporated (INSM) Earnings: An Early Look
Earnings season is winding down, with most companies already having reported their quarterly results.
Does Novartis AG (ADR) (NVS)’s Dividend Have Room to Soar?
With interest rates still sitting near record lows, looking for current income have been forced to move away from fixed-income positions and into stocks to find yield.
Can Myriad Genetics, Inc. (MYGN) Survive the Supreme Court?
The market has been less than thrilled about an upcoming Supreme Court decision on the legality of the best-selling analytical test of Myriad Genetics, Inc. (NASDAQ:MYGN) .
